PT3993777T - Composições comprimidas de macitentano, métodos e usos das mesmas - Google Patents
Composições comprimidas de macitentano, métodos e usos das mesmasInfo
- Publication number
- PT3993777T PT3993777T PT207503582T PT20750358T PT3993777T PT 3993777 T PT3993777 T PT 3993777T PT 207503582 T PT207503582 T PT 207503582T PT 20750358 T PT20750358 T PT 20750358T PT 3993777 T PT3993777 T PT 3993777T
- Authority
- PT
- Portugal
- Prior art keywords
- macitentan
- compressed
- compositions
- methods
- macitentan compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT2019115632 | 2019-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3993777T true PT3993777T (pt) | 2024-09-05 |
Family
ID=67211642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT207503582T PT3993777T (pt) | 2019-07-05 | 2020-07-03 | Composições comprimidas de macitentano, métodos e usos das mesmas |
Country Status (1)
| Country | Link |
|---|---|
| PT (1) | PT3993777T (pt) |
-
2020
- 2020-07-03 PT PT207503582T patent/PT3993777T/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285302A (en) | Compounds, preparations and methods | |
| SG11202108367XA (en) | Immunomodulators, compositions and methods thereof | |
| IL285651A (en) | Anti-trem2 antibodies, preparations containing them and their uses | |
| GB202017595D0 (en) | Compositions, and methods and uses relating thereto | |
| GB201901099D0 (en) | Methods, uses and compositions | |
| GB202017593D0 (en) | Compositions and methods and uses relating thereto | |
| GB2576614B (en) | Compositions, uses and methods | |
| GB201911367D0 (en) | Composition, paste and methods | |
| GB201910100D0 (en) | Composition, paste and methods | |
| HUE068040T2 (hu) | Préselt macitentán készítmények, eljárások és ezek felhasználása | |
| IL287120A (en) | Compounds, preparations and methods | |
| GB201804163D0 (en) | Uses, compositions and methods | |
| GB2613256B (en) | Compositions, and methods and uses relating thereto | |
| ZA202104192B (en) | Mmpl3 inhibitors, compositions and uses thereof | |
| GB2609091B (en) | Compositions, and methods and uses relating thereto | |
| GB201909298D0 (en) | Novel compositions and uses thereof | |
| LT3993777T (lt) | Presuotos macitentano kompozicijos, būdai ir jų naudojimas | |
| PT3993777T (pt) | Composições comprimidas de macitentano, métodos e usos das mesmas | |
| ZA202005050B (en) | Polypeptide, compositions and uses thereof | |
| SG11202108262VA (en) | Bacterialcidal methods and compositions | |
| GB201915010D0 (en) | Composition, paste and methods | |
| GB2586313B (en) | Compositions and methods and uses relating thereto | |
| GB201907351D0 (en) | Compositions and uses thereof | |
| GB201905690D0 (en) | Compositions and uses thereof | |
| GB201905593D0 (en) | Compositions and uses thereof |